France· FR:69969425
THYROZOL 10 mg, comprimé pelliculé sécable
A thiamazole product containing thiamazole, registered in France by MERCK SANTE, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Thiamazole is registered in 12 of 19 countries.
Countries holding a registration under ATC H03BB02 (thiamazole), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Thiamazole · ATC H03BB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Polandprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of thiamazole costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- France: $0.12 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Thiamazole · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.12
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- THIAMAZOLE
- Manufacturer
- MERCK SANTE
- Country
- France (FR)
- ATC code
- H03BB02
- ATC class
- Thiamazole
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400939111919plaquette(s) PVC-Aluminium de 30 comprimé(s)EUR 3.15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
170 interactions on record for thiamazole.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thiamazole · interactions on record
170 records
- 10 severe
- 42 moderate
- 2 minor
- 116 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Thiamazole in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTHYROZOLMERCK spol. s r.o., Praha
- PolandThyrozolInPharm Sp. z o.o.
- United StatesmethimazoleViona Pharmaceuticals Inc.
- FinlandApelka VetNorbrook Laboratories (Ireland) Limited
- CanadaFELIMAZOLE 1.25 MGDECHRA LTD
- GermanyMethizol SdMibe Gmbh Arzneimittel
- SwedenThacapzol 5 mg TablettViatris AB
- NetherlandsStrumazol 10 mg, tablettenAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Thiamazol Sandoz
- Belgium · Strumazol
- Bulgaria · Метизол, Тирозол
- Cyprus · Unimazole
- Czechia · Thyrozol
- Germany · Methizol Sd, Thiamazol
- Denmark · Thiamazole "uni-Pharma", Thycapzol
- Estonia · Thyrozol
- Spain · Tirodril
- Greece · Unimazole
- Croatia · Athyrazol
- Hungary · Metothyrin
- Iceland · Thiamazole Uni-Pharma
- Italy · Tapazole
- Lithuania · Metizol, Thyrozol
- Luxembourg · Strumazol, Thyrozol
- Latvia · Thyrozol
- Netherlands · Strumazol
- Poland · Metizol, Thyrozol
- Portugal · Metibasol
- Romania · Thyrozol
- Sweden · Thacapzol, Thiamazole Uni-Pharma
- Slovenia · Athyrazol
- Slovakia · Thyrozol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5eac87c4-4050-4bb3-ad1f-1686285fbd9c GET /v1/drugs/5eac87c4-4050-4bb3-ad1f-1686285fbd9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69969425",
"date_amm": "2009-02-23",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "THIAMAZOLE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about thiamazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.